High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.

about

Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.

P2860

Q47339574-EC29D9E7-8CB1-45E8-92D2-1330B23791E5

P2860

High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.

Item

http://www.wikidata.org/entity/Q38414170

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.

@en

type

Item

label

High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.

@en

prefLabel

High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.

@en

P1476

High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer

@en

P2093

Chan Heun Park

http://www.w3.org/2001/XMLSchema#string

Dong Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Dong-Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Hyun Joo Lee

http://www.w3.org/2001/XMLSchema#string

Jin Hee Sohn

http://www.w3.org/2001/XMLSchema#string

Jung-Soo Pyo

http://www.w3.org/2001/XMLSchema#string

Kyoung Min Moon

http://www.w3.org/2001/XMLSchema#string

Kyungeun Kim

http://www.w3.org/2001/XMLSchema#string

Mi Jung Kwon

http://www.w3.org/2001/XMLSchema#string

Seon Hyeong Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer

Molecular portraits of human breast tumours

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

A gene-expression signature to predict survival in breast cancer across independent data sets.

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models.

Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.

P304

707-714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/POSTGRADMEDJ-2015-133531

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1094

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kyueng-Whan Min

P577

2016-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27222586

http://www.w3.org/2001/XMLSchema#string

High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.

about

P2860

P2860

High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698